上皮V2受体通过YAP-CCN2依赖机制调控多囊肾病肌成纤维细胞
本研究探讨常染色体显性多囊肾病(ADPKD)中囊上皮细胞V2受体是否通过旁分泌刺激间质肌成纤维细胞和纤维化。在Pkd1敲除小鼠中,dDAVP激活V2R增加肌成纤维细胞和细胞外基质沉积;人ADPKD囊上皮细胞条件培养基同样激活肌成纤维细胞。集合管特异性敲除CCN2减少囊肿生长和肌成纤维细胞,YAP调控CCN2,YAP抑制或敲除减少纤维化并阻断dDAVP效应。结论提示V2R-YAP-CCN2通路是ADPKD纤维化的潜在治疗靶点。
要点
- V2R激动剂dDAVP可增加Pkd1KO小鼠肾间质肌成纤维细胞和ECM沉积。
- 囊上皮细胞通过旁分泌机制激活肌成纤维细胞,CCN2和YAP是关键介质。
- YAP抑制或基因敲除可减少Pkd1KO小鼠肾纤维化并阻断dDAVP效应。
核心结论
- 囊上皮细胞V2R通过YAP-CCN2依赖机制旁分泌刺激肌成纤维细胞,促进ADPKD纤维化。
- V2R-YAP-CCN2信号通路可能是ADPKD纤维化的潜在治疗靶点。
研究设计与样本
- 使用Pkd1基因敲除(Pkd1KO)小鼠,以dDAVP(V2R激动剂)处理3天。
- 分析人ADPKD囊上皮细胞原代培养的条件培养基对肌成纤维细胞活化的影响。
- 采用集合管特异性CCN2基因敲除、YAP抑制或基因敲除等方法验证机制。
主要发现
- dDAVP处理增加Pkd1KO小鼠肾间质肌成纤维细胞数量和ECM沉积。
- 人ADPKD囊上皮细胞条件培养基在体外增加肌成纤维细胞活化,提示旁分泌机制。
- 集合管特异性敲除CCN2显著减少Pkd1KO小鼠肾脏囊肿生长和肌成纤维细胞。
- YAP调控CCN2,YAP抑制或基因敲除减少Pkd1KO小鼠肾纤维化。
- YAP失活阻断dDAVP诱导的Pkd1KO肾脏肌成纤维细胞增加;体外显示V2R通过ERK1/2依赖机制调控YAP。
临床怎么用
- 靶向V2R-YAP-CCN2通路可能为ADPKD纤维化提供治疗策略。
- 需进一步临床研究验证该通路在ADPKD患者中的治疗价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fibrosis is a major cause of loss of renal function in autosomal dominant polycystic kidney disease (ADPKD). In this study, we examined whether vasopressin type-2 receptor (V2R) activity in cystic epithelial cells can stimulate interstitial myofibroblasts and fibrosis in ADPKD kidneys. METHODS: We treated Pkd1 gene knockout (Pkd1KO) mice with dDAVP, a V2R agonist, for 3 days and evaluated the effect on myofibroblast deposition of extracellular matrix (ECM). We also analyzed the effects of conditioned media from primary cultures of human ADPKD cystic epithelial cells on myofibroblast activation. Because secretion of the profibrotic connective tissue growth factor (CCN2) increased significantly in dDAVP-treated Pkd1KO mouse kidneys, we examined its role in V2R-dependent fibrosis in ADPKD as well as that of yes-associated protein (YAP). RESULTS: V2R stimulation using dDAVP increased the renal interstitial myofibroblast population and ECM deposition. Similarly, conditioned media from human ADPKD cystic epithelial cells increased myofibroblast activation in vitro, suggesting a paracrine mechanism. Renal collecting duct-specific gene deletion of CCN2 significantly reduced cyst growth and myofibroblasts in Pkd1KO mouse kidneys. We found that YAP regulates CCN2, and YAP inhibition or gene deletion reduces renal fibrosis in Pkd1KO mouse kidneys. Importantly, YAP inactivation blocks the dDAVP-induced increase in myofibroblasts in Pkd1KO kidneys. Further in vitro studies showed that V2R regulates YAP by an ERK1/2-dependent mechanism in human ADPKD cystic epithelial cells. CONCLUSIONS: Our results demonstrate a novel mechanism by which cystic epithelial cells stimulate myofibroblasts in the pericystic microenvironment, leading to fibrosis in ADPKD. The V2R-YAP-CCN2 cell signaling pathway may present a potential therapeutic target for fibrosis in ADPKD.
引用
- Dwivedi N, Tao S, Jamadar A, et al. Epithelial Vasopressin Type-2 Receptors Regulate Myofibroblasts by a YAP-CCN2-Dependent Mechanism in Polycystic Kidney Disease. J Am Soc Nephrol. 2020. PMID: 32554753. doi:10.1681/ASN.2020020190
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。